A method for diagnosing a
genetic predisposition in a subject for diseases, disorders or conditions including a
diabetic kidney complication such as
kidney disease of type 2 diabetes or type 1 diabetes,
end stage renal disease (ESRD) due to type 2 diabetes, ESRD due to hypertension in type 2 diabetes, ESRD due to type 1 diabetes; cardiovascular diseases due to type 2 diabetes or type 1 diabetes such as atherosclerotic
peripheral vascular disease, hypertension,
ischemic cardiomyopathy, and
myocardial infarction due to type 2 diabetes or type 1 diabetes; and cerebrovascular accident due to type 2 diabetes. At least one
polynucleotide is analyzed to detect a
single nucleotide polymorphism (SNP), in which the presence of the
single nucleotide polymorphism indicates that the subject is suffering from, at risk for, or suspected of suffering from the diseases, disorders or conditions. Also provided is an array or kit for diagnosing the
genetic predisposition.